PhaseBio reports promising phase I results with ticagrelor reversal agent PB-2452 Sep. 25, 2018 No Comments
Efgartigimod phase II data in ITP support progression to phase III development Sep. 17, 2018 No Comments
European Commission approves Veyvondi for adults with von Willebrand disease Sep. 12, 2018 No Comments
Positive results reported across multiple endpoints in ZENITH-1 trial of oral BCX-7353 Sep. 5, 2018 No Comments
European Commission approves Cablivi for acquired thrombotic thrombocytopenic purpura Sep. 3, 2018 No Comments
RSS